Diabetic retinopathy

Information for UK clinicians

Every Diabetic Retinopathy Screening Service is required to deliver an annual report to the Diabetic Retinopathy (DR) National Screening Committee (NSC) so that the quality of the service provided is assured.

A major part of this annual report relies on the return of data from Hospital Eye Services (HES).

At present almost no screening programmes have been able to provide an accurate, comprehensive annual report using paper based processes.

When Medisoft’s DR structured assessment screen is completed for all patients referred from DR screening programmes to the HES, the software will be able to generate an annual report of all data that is required from the HES.

  • This can then be delivered to the screening service, where it can be used to produce a complete report.
  • At sites where Medisoft can automatically link with the DR screening software this data exchange is automated.

Medisoft is the only company to fulfill the data collection requirements defined in the Connecting for Health Do Once and Share Diabetic Eye Disease project. Such data collection is recommended by the Royal College of Ophthalmologists to improve the quality of care of patients with diabetic retinopathy and to deliver detailed audit of clinical outcomes.

Medisoft’s structured assessment of DR encourages clinicians to document the clinical signs of retinopathy and maculopathy and the software will then automatically grade the retinopathy according to the NSC, ETDRS and international classifications of DR.

Decision support functions will automatically highlight variation between the grade of retinopathy and maculopathy defined by the screening service and the hospital eye service.